Bajaj Healthcare shares climbed more than 17% after the pharmaceutical company signed a definitive contract agreement with customers in the United Kingdom and the European...
Bajaj Healthcare shares rallied 8% during the early trading hours on 14 September after the company received an Establishment Inspection Report (EIR) from the USFDA...
On Friday, Bajaj Healthcare Ltd said it has successfully completed a pre-approval inspection by US health regulators at its active pharmaceutical ingredient plant in Vadodara,...